Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3 – Fierce Biotech

1. Pfizer’s mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3  Fierce Biotech
2. Pfizer’s mRNA flu shot trumps inactivated vaccine in late-stage study  FirstWord Pharma
3. Today’s biggest science news: Comet 3I/ATLAS images | U.S….

Continue Reading

News Source: www.fiercebiotech.com